Systematic analysis identifies TRIM22 as an oncogenic and immunological biomarker in glioma

Systematic analysis identifies TRIM22 as an oncogenic and immunological biomarker in glioma

Abstract The regulatory role of tripartite motif-containing 22 (TRIM22) has been reported in multiple types of cancers and disease, however, its potential role in gliomas remains poorly understood. In this study, we aimed to elucidate the biological role of TRIM22 in gliomas. The expression levels o...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuanyuan Hu, Haimei Zhi, Amin Zhang, Siyu Lu, Chen Zhang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Glioma
TRIM22
Prognosis
Immunomodulation
Oncogenic
Online Access:https://doi.org/10.1186/s12885-025-14612-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items